Carlyle Group Inc. (CGABL) SEC Filings — 2024

Filings

• Carlyle Group Files 13D/A for QuidelOrtho — SC 13D/A · Nov 21, 2024
• Carlyle Group Inc. SC 13D/A Filing - Amendment 16 — SC 13D/A · Nov 15, 2024
• Carlyle Group Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Carlyle Group Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
• Carlyle Group Inc. SC 13G/A Filing — SC 13G/A · Nov 8, 2024
• Carlyle Group Inc. 13F-HR Filing — 13F-HR · Nov 8, 2024
• Carlyle Group Inc. 10-Q Filing — 10-Q · Nov 7, 2024
• Carlyle Group Inc. SC 13G/A Filing — SC 13G/A · Oct 24, 2024
• Carlyle Group Inc. Files SC 13D/A for Soleno Therapeutics — SC 13D/A · Oct 21, 2024
• Carlyle Group Amends Soleno Therapeutics Stake — SC 13D/A · Oct 15, 2024
• Carlyle Group Inc. Files SC 13D/A Amendment — SC 13D/A · Oct 10, 2024
• Carlyle Group Inc. Amends Soleno Therapeutics Stake — SC 13D/A · Sep 10, 2024
• Carlyle Group Inc. 13F-HR Filing — 13F-HR · Aug 9, 2024
• Carlyle Group Q2 2024 Update: Shares Outstanding & Debt Noted — 10-Q · Aug 6, 2024
• Carlyle Group Inc. Files 8-K on Financials — 8-K · Aug 5, 2024
• Carlyle Group Inc. Amends QuidelOrtho Stake Filing — SC 13D/A · Aug 5, 2024
• Carlyle Group Files 13D/A for QuidelOrtho Corp — SC 13D/A · Jul 30, 2024
• Carlyle Group Amends QuidelOrtho Stake Filing — SC 13D/A · Jul 24, 2024
• Carlyle Group Inc. Amends QuidelOrtho Stake Filing — SC 13D/A · Jul 15, 2024
• Carlyle Group Inc. SC 13G/A Filing — SC 13G/A · Jul 11, 2024
• Carlyle Group Files SC 13D for Cano Health — SC 13D · Jul 8, 2024
• Carlyle Group Inc. Amends QuidelOrtho Corp. Ownership Filing — SC 13D/A · Jun 25, 2024
• Carlyle Group Inc. Announces Board and Executive Changes — 8-K · May 31, 2024
• Carlyle Group Inc. Amends 13D Filing for QuidelOrtho Corp. — SC 13D/A · May 14, 2024
• Carlyle Group Inc. Amends Filing for eFFECTOR Therapeutics Stake — SC 13D/A · May 13, 2024
• Carlyle Group Inc. Q1 2024 10-Q Filing — 10-Q · May 7, 2024
• Carlyle Group Inc. 13F-HR Filing — 13F-HR · May 3, 2024
• Carlyle Group Files 8-K on Financials — 8-K · May 1, 2024
• Carlyle Group Inc. Files Definitive Proxy Statement (DEF 14A) — DEF 14A · Apr 18, 2024
• Carlyle Group Inc. Files 8-K: Director/Officer Changes & Financials — 8-K · Apr 3, 2024
• Carlyle Group Inc. SC 13G Filing — SC 13G · Mar 29, 2024
• Carlyle Group Inc. Files 8-K on Officer/Director Changes — 8-K · Mar 27, 2024
• Carlyle Group Inc. Files SC 13D/A Amendment — SC 13D/A · Mar 5, 2024
• Carlyle Group Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 22, 2024
• Carlyle Group Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• Carlyle Group Amends Jasper Therapeutics Stake, Signals Ownership Update — SC 13D/A · Feb 12, 2024
• Morgan Stanley Amends Carlyle Group Stake, Files SC 13G/A — SC 13G/A · Feb 12, 2024
• Capital World Investors Takes 19.97M Share Stake in Carlyle Group — SC 13G · Feb 9, 2024
• Carlyle Group Amends Adicet Bio Stake on Jan 25 Event — SC 13D/A · Feb 7, 2024
• Carlyle Group Confirms Nasdaq Listing for Common Stock & Subordinated Notes — 8-K · Feb 7, 2024
• Carlyle Group Reveals Q4 2023 Holdings: Big Bets on Getty, GDS — 13F-HR · Feb 2, 2024
• BlackRock Discloses Carlyle Group Common Stock Holdings — SC 13G · Jan 25, 2024
• Carlyle Group Confirms Nasdaq Listing & Subordinated Notes Registration — 8-K · Jan 18, 2024
• Carlyle Group Amends CommScope Stake, Signals Ownership Change — SC 13D/A · Jan 3, 2024